The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis study
β Scribed by T. W. O'Neill; D. Felsenberg; J. Varlow; C. Cooper; J. A. Kanis; A. J. Silman
- Publisher
- American Society for Bone and Mineral Research
- Year
- 2009
- Tongue
- English
- Weight
- 803 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0884-0431
No coin nor oath required. For personal study only.
β¦ Synopsis
Our aim was to determine the prevalence of radiographically defined vertebral deformity, as a marker of vertebral osteoporosis, in different regions and populations within Europe. We used a cross-sectional population-based survey. Population-based sampling frames were obtained from 36 centers in 19 European countries. Stratified random sampling was used to recruit 15,570 males and females aged 50-79 years. Lateral spinal radiographs were taken according to a standardized protocol, and all X-rays were evaluated centrally. Vertebral deformity was morphometrically defined according to the published methods of McCloskey and Eastell. Based on the McCloskey method, the mean center prevalence of all deformities was 12% in females (range 6-21%) and 12% in males (range 8-2W0). The prevalence increased with age in both sexes though the gradient was steeper in females. There was substantial geographical variation, with the highest rates in Scandinavian countries. Radiographically defined vertebral deformity is a common disorder and equally frequent in males and females. Using standardized methodology, there is important variation in occurrence across Europe, which might suggest clues to pathogenesis.
π SIMILAR VOLUMES
## Abstract A new standardized scoring method was used to study age variation of the degree of fusion of the ventral face of the sacral vertebral bodies (SVF) in 904 adult skeletons of both sexes from two identified modern samples (20th c.): Frassetto collections (Museum of Anthropology, University
## Abstract In the Fracture Intervention Trial (FIT) Long Term Extension (FLEX) Trial, 10 years of alendronate (ALN) did not significantly reduce the risk of nonvertebral fractures (NVFs) compared with 5 years of ALN. Continuing ALN reduced the risk of clinical but not morphometric vertebral fractu
## Abstract ## Objectives We determined levels of cognitive functioning in community dwelling men aged 40β79 (__n__β=β3265) from eight European centres and investigated to what extent cognitive performance varied between centres, the association between different cognitive domains and age, educati
## Abstract ## Objective Lateβlife depression is one of the main health problems among elderly populations and a key element of healthy ageing. Causal relationships of lifestyleβ and dietβrelated factors in lateβlife depression are unclear. This study investigates prospective associations of lifes